Persistent infection
Information
- Disease name
- Persistent infection
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04704908 | Active, not recruiting | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | February 6, 2021 | December 2023 | |
NCT02562508 | Completed | Phase 3 | A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls | December 5, 2015 | August 12, 2016 |
NCT02740777 | Completed | Phase 2 | Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females | February 2016 | July 2019 |
NCT05426148 | Completed | Phase 4 | Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female | May 1, 2020 | April 30, 2021 |
NCT03206255 | Completed | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls | July 1, 2017 | August 15, 2018 | |
NCT01735006 | Completed | Phase 3 | Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine | November 22, 2012 | October 18, 2019 |
NCT04954638 | Enrolling by invitation | The Effectiveness of Hyperpure Chlorine Dioxide and Sodium Hypochlorite Irrigants in Endodontic Retreament in RCT | November 15, 2019 | July 31, 2025 | |
NCT06243666 | Not yet recruiting | Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls | February 20, 2024 | December 31, 2026 | |
NCT05045755 | Recruiting | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | April 13, 2021 | January 2024 | |
NCT05621343 | Recruiting | New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis | December 21, 2021 | December 2024 | |
NCT06159725 | Recruiting | Phase 1/Phase 2 | A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis | January 17, 2024 | February 2025 |
NCT04969445 | Recruiting | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | March 30, 2021 | January 2024 |